1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer>

BOARD HIGHLIGHTS FOR SEPTEMBER 14 & 15 2023

The CMLTO Board of Directors met on September 14 & 15 2023 via Zoom. A few highlights from the meetings include:

Validation of CMLTO Ends (Critical Outcomes) Policies for 2024 to 2026/2027
The CMLTO serves the public interest through achievement of the CMLTO Critical Outcomes/Ends Policies, which are developed by the Board of Directors to ensure safe medical laboratory technology practice and high-quality healthcare in Ontario.

The CMLTO Board regularly monitors the achievement of its Ends (Critical Outcomes) Policies through the monitoring reports presented to the Board of Directors, which include data/evidence to demonstrate progress toward achievement of the Ends Policies.

The current Ends Policy direction provided by the CMLTO Board covered the period from 2019 to 2023. At its September meeting, the CMLTO Board approved the CMLTO Ends (Critical Outcomes) Policies for 2024 to 2026 / 2027.

Please click here to review the CMLTO Ends (Critical Outcomes) Policies for 2024 to 2026 / 2027.

CMLTO By-Law: Special Review for Emergency Class Registration
The Health Professions Procedural Code set out in Schedule 2 to the Regulated Health Professions Act, 1991 (Section 16.3 "Emergency Classes of Registration") mandates all Health Regulatory Colleges to establish a new emergency class of registration.

At its meeting on April 20, 2023, the Board of Directors approved the amendments to the CMLTO's registration requirements, which are defined Ontario Regulation 207/94 (Part 1 – Registration) under the Medical Laboratory Technology Act, 1991. The amendments to the CMLTO Registration Regulation were enacted by the Ministry of Health in August 2023.

At its September meeting, the CMLTO Board approved the proposed amendments to the CMLTO By-Law regarding Emergency Class of Registration and circulation of these revisions to CMLTO Registrants for a minimum of sixty (60) days. Any input received from this consultation will be considered prior to the approval of the revised CMLTO By-Law.

Approval of Two New Board Policies
The CMLTO Board of Directors not only regularly reviews its By-Law and policies to ensure that all CMLTO governance documents are in alignment, current and transparent, but also conducts an ongoing gap analysis to ensure that its By-Law and policies accurately reflect the the direction of the College, match its mission, goals of governance and current legislation in pursuit of public interest.

To that end, the CMLTO Board of Directors approved two new Board Policies at its September meeting:

  1. New Governance Process Policy:
    (GP IV-170) Emergency Class of Registration Policy.
    (GP IV-170) Emergency Class of Registration Policy is intended to guide the CMLTO Board of Directors in enabling and expediting emergency registration under extraordinary circumstances, which warrant regulatory intervention, pursuant to the CMLTO classes of certificate of registration and registration requirements as outlined in Ontario Regulation 207/94 (Part 1 – Registration) under the Medical Laboratory Technology Act, 1991.
  2. New Executive Limitations Policy:
    (EL II-12) Financial Audit and External Auditors Policy
    (EL II-12) Financial Audit and Auditors Policy, which outlines the Board's executive risk boundaries for the Registrar and CEO with regards to financial audit and audit related matters, serves as the principal guidance document for the conduct of the financial audit by external auditors and a framework for the assessment of the effectiveness and efficiency of the external auditor.
Modifications to the Board Monitoring or Registrar and CEO Process
The CMLTO Board regularly monitors the achievement of its Ends (Critical Outcomes) Policy and compliance with its Executive Limitations Policies through the monitoring reports presented to the Board of Directors by the Registrar and CEO.

The Registrar and CEO Ends and Executive Limitations Policy monitoring reports, which are intended to provide the Board of Directors with data and evidence to assist it with Registrar & CEO performance assessment, and hence, considered to be a confidential human resources matter, have always been presented to the Board of Directors in closed meetings in accordance with Section 7(2)(d) of the Health Professions Procedural Code, being Schedule 2 of the Regulated Health Professions Act, 1991.

The CMLTO Board is committed to transparency and accountability and supports disclosure of information pertaining to results and progress on Ends (Critical Outcomes) Policy achievement and compliance with the Executive Limitations Policies publicly in pursuit of public interest, even though this information is also used for the assessment of the Registrar and CEO performance.

Therefore, moving forward, Registrar and CEO Ends and Executive Limitations monitoring reports will be presented to the Board of Directors in open Board meetings to demonstrate progress on achievement of Ends (Critical Outcomes) Policies and compliance with Executive Limitations Policies in pursuit of transparency and accountability.

Please click here for further information on the other actions taken by the Board of Directors at its September meeting.

Next CMLTO Board Meetings
The next CMLTO Board meetings will be held on December 11 & 12, 2023.

Read More CMLTO News